Page last updated: 2024-09-03
1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane and Prostatic Neoplasms
1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane has been researched along with Prostatic Neoplasms in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Balachandran, R; Day, BW; Grant, SG; Welsh, MJ | 1 |
Other Studies
1 other study(ies) available for 1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane and Prostatic Neoplasms
| Article | Year |
|---|---|
Z-1,1-Dichloro-2,3-diphenylcyclopropanes block human prostate carcinoma cell proliferation, inhibit prostate-specific antigen expression, and initiate apoptosis.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Growth Inhibitors; Humans; Male; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Tamoxifen; Tumor Cells, Cultured | 2000 |